Literature DB >> 15591585

Proinflammatory properties of IL-4 in the intestinal microenvironment.

C Van Kampen1, J Gauldie, S M Collins.   

Abstract

IL-4 is involved in type 2 T helper cell (Th)2-type immune responses and, in some cases, can promote Th1 responses. However, the proinflammatory potential of IL-4 alone is unclear. In this study, we examined the ability of IL-4 to induce colitis after its overexpression in the colon using an adenoviral vector (Ad5) and compared results with those obtained after overexpression of IL-12, a cytokine implicated in several models of colitis. Overexpression of IL-4 or IL-12 caused a fatal colitis within 24 h in 60% of animals and was dose and strain dependent. IL-12-induced colitis was accompanied by the local expression of IFN-gamma and TNF-alpha but not IL-4 mRNA and protein. Conversely, IL-4-induced colitis was accompanied by the local expression of IL-4 and TNF-alpha but not IFN-gamma mRNA and protein. The Ad5-IL4-induced colitis did not persist beyond 3 days and was present in recombinase activation gene-2 (RAG-2)-/- mice but not in STAT6-/- mice. Acute lethal colitis induced by Ad5IL12 was T cell mediated and IFN-gamma receptor (IFN-gamma R) dependent. Furthermore, TNF-alpha was found to be important in the pathogenesis of Ad5IL-4 and Ad5IL-12-induced colitis. Results of this study indicate that IL-4 alone can act as a proinflammatory cytokine in the gut of normal mice, inducing a rapid onset and short-lived colonic injury while maintaining a Th2-type cytokine profile that functions via a local T cell-independent mechanism involving TNF-alpha.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15591585     DOI: 10.1152/ajpgi.00014.2004

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  18 in total

1.  Concurrent infection with an intestinal helminth parasite impairs host resistance to enteric Citrobacter rodentium and enhances Citrobacter-induced colitis in mice.

Authors:  Chien-Chang Chen; Steve Louie; Beth McCormick; W Allan Walker; Hai Ning Shi
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

2.  IL4 in the 5q31 context: association studies of type 1 diabetes and rheumatoid arthritis in the Spanish population.

Authors:  Concepción Nuñez; Jose Luis Santiago; Jezabel Varadé; Hermenegildo de la Calle; M Angeles Figueredo; Benjamín Fernandez-Gutierrez; Emilio G de la Concha; Elena Urcelay; Alfonso Martínez
Journal:  Immunogenetics       Date:  2007-12-07       Impact factor: 2.846

Review 3.  Dark Agouti rat model of chemotherapy-induced mucositis: establishment and current state of the art.

Authors:  Barbara Vanhoecke; Emma Bateman; Bronwen Mayo; Eline Vanlancker; Andrea Stringer; Daniel Thorpe; Dorothy Keefe
Journal:  Exp Biol Med (Maywood)       Date:  2015-05-12

Review 4.  JAK-STAT pathway targeting for the treatment of inflammatory bowel disease.

Authors:  Azucena Salas; Cristian Hernandez-Rocha; Marjolijn Duijvestein; William Faubion; Dermot McGovern; Severine Vermeire; Stefania Vetrano; Niels Vande Casteele
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-03-19       Impact factor: 46.802

Review 5.  Targeting the gastrointestinal tract with viral vectors: state of the art and possible applications in research and therapy.

Authors:  Roeland Buckinx; Jean-Pierre Timmermans
Journal:  Histochem Cell Biol       Date:  2016-09-24       Impact factor: 2.531

6.  Intestinal tête-à-tête: helminths blunt immunity against flaviviruses.

Authors:  David E Place; Thirumala-Devi Kanneganti
Journal:  Cell Res       Date:  2021-07       Impact factor: 46.297

7.  Interleukin-4 and interleukin-13 increase NADPH oxidase 1-related proliferation of human colon cancer cells.

Authors:  Han Liu; Smitha Antony; Krishnendu Roy; Agnes Juhasz; Yongzhong Wu; Jiamo Lu; Jennifer L Meitzler; Guojian Jiang; Eric Polley; James H Doroshow
Journal:  Oncotarget       Date:  2017-06-13

Review 8.  Anti-Inflammatory Targets for the Treatment of Reperfusion Injury in Stroke.

Authors:  Atsushi Mizuma; Midori A Yenari
Journal:  Front Neurol       Date:  2017-09-07       Impact factor: 4.003

Review 9.  Phytochemicals Targeting JAK-STAT Pathways in Inflammatory Bowel Disease: Insights from Animal Models.

Authors:  Sun Young Moon; Kwang Dong Kim; Jiyun Yoo; Jeong-Hyung Lee; Cheol Hwangbo
Journal:  Molecules       Date:  2021-05-10       Impact factor: 4.411

Review 10.  Integrating Immunologic Signaling Networks: The JAK/STAT Pathway in Colitis and Colitis-Associated Cancer.

Authors:  Sebastian Zundler; Markus F Neurath
Journal:  Vaccines (Basel)       Date:  2016-02-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.